Recent News: Molecular Pathology & Diagnostics

Share
Print
and/or
Upcoming Seminars and Events
Read more
View upcoming seminars and events
8 News Items found
In the Clinic
Man and woman in white lab coats looking at test tubes
Single-Cell Analysis Enables Researchers to Understand the Differences within Tumors

By Julie Grisham

Scientists are decoding the genetic changes that drive individual cancer cells. This may help them develop more-effective targeted therapies.
Tags: Cancer Care · Diagnosis · Pathology · Treatment · Personalized Medicine · Targeted Therapy · Cancer Genetics & Genomics · Sloan Kettering Institute · Molecular Pathology & Diagnostics
Science Byte
Prostate cancer cells, colored red in scanning electron micrograph (SEM).
PSMA: A New Target for Prostate Cancer Treatment

By Jim Stallard

Researchers have discovered how a high level of the protein PSMA in cells helps fuel prostate cancer.
Tags: Cell Signaling & Regulation · Discoveries & Advances · Molecular Pathology & Diagnostics
Announcement
Christina Leslie and John Petrini
Expanding the Impact of Precision Medicine to Fuel Discoveries

By Jim Stallard

MSK’s Functional Genomics Initiative will enable basic scientists to take full advantage of the massive amount of data produced by tumor sequencing.
Tags: Lab Research · Cancer Genetics & Genomics · Research · Genetic Testing · Pathology · Cell Signaling & Regulation · Computational Oncology · Genome Integrity · Molecular Pathology & Diagnostics · Solid Tumor Oncogenesis · Systems Biology
Finding
MSK investigators Michael Berger and David Solit.
Study Reveals How Some Breast Cancers Become Resistant to Targeted Drugs

By Julie Grisham

A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors.
Tags: Cancer Care · Clinical Trials · Targeted Therapy · Cancer Genetics & Genomics · Discoveries & Advances · Metastasis & Drug Resistance · Molecular Pathology & Diagnostics · Targeted Therapy
In the Lab
Pictured: Scott Lowe
Researchers Uncover Potential Target for “Undruggable” Form of Liver Cancer

By Eva Kiesler

In taking a new approach to finding treatments for hepatocellular carcinoma, MSK scientists have uncovered a potential drug target for this highly aggressive cancer.
Tags: Research · Cancer Genetics & Genomics · Discoveries & Advances · Lab Research · Metastasis & Drug Resistance · Molecular Pathology & Diagnostics · Solid Tumor Oncogenesis · Targeted Therapy
Decoder
Pictured: Gum ball machines
What Is Tumor Heterogeneity?

By Eva Kiesler

Understanding tumor heterogeneity may be the next big quest in cancer science, as differences between cells within a tumor can have important consequences for how cancers are diagnosed and treated.
Tags: Lab Research · Discoveries & Advances · Cancer Genetics & Genomics · Research · Cell Signaling & Regulation · Computational Oncology · Metastasis & Drug Resistance · Molecular Pathology & Diagnostics · Solid Tumor Oncogenesis · Tumor Microenvironment
Feature
Pictured: Michael Berger & David Solit
Cancer Genomics: New Technologies Speed Discovery and Expand Opportunities for Personalized Medicine

By Eva Kiesler

At Memorial Sloan Kettering, new technologies to study gene changes in cancer cells are accelerating the development and implementation of more-effective treatments.
Tags: Research · Cancer Genetics & Genomics · Computational Oncology · Molecular Pathology & Diagnostics

Researchers Find Genetic Key to Breast Cancer's Ability to Survive and Spread

New research led by investigators at Memorial Sloan Kettering Cancer Center sheds light on a genetic function that gives breast cancer cells the ability to survive and spread to the bone years after treatment has been administered.

  • Monday, July 6, 2009